- Home
- NABL vs BEAM Comparison
NABL vs BEAM Comparison
Compare NABL & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NABL
- BEAM
- Stock Information
- Founded
- NABL 2000
- BEAM 2017
- Country
- NABL United States
- BEAM United States
- Employees
- NABL N/A
- BEAM N/A
- Industry
- NABL Computer Software: Prepackaged Software
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NABL Technology
- BEAM Health Care
- Exchange
- NABL Nasdaq
- BEAM Nasdaq
- Market Cap
- NABL 2.0B
- BEAM 1.9B
- IPO Year
- NABL N/A
- BEAM 2020
- Fundamental
- Price
- NABL $10.54
- BEAM $24.05
- Analyst Decision
- NABL Buy
- BEAM Buy
- Analyst Count
- NABL 4
- BEAM 11
- Target Price
- NABL $15.50
- BEAM $45.90
- AVG Volume (30 Days)
- NABL 445.8K
- BEAM 1.3M
- Earning Date
- NABL 11-07-2024
- BEAM 11-05-2024
- Dividend Yield
- NABL N/A
- BEAM N/A
- EPS Growth
- NABL 72.50
- BEAM N/A
- EPS
- NABL 0.20
- BEAM N/A
- Revenue
- NABL $458,053,000.00
- BEAM $349,643,000.00
- Revenue This Year
- NABL $11.99
- BEAM N/A
- Revenue Next Year
- NABL $8.73
- BEAM $6.04
- P/E Ratio
- NABL $52.75
- BEAM N/A
- Revenue Growth
- NABL 11.93
- BEAM 328.73
- 52 Week Low
- NABL $10.52
- BEAM $20.84
- 52 Week High
- NABL $15.49
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- NABL 20.54
- BEAM 46.67
- Support Level
- NABL $12.34
- BEAM $21.46
- Resistance Level
- NABL $11.26
- BEAM $32.29
- Average True Range (ATR)
- NABL 0.32
- BEAM 2.04
- MACD
- NABL -0.17
- BEAM 0.19
- Stochastic Oscillator
- NABL 0.69
- BEAM 23.92
About NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. it also has a presence in the United Kingdom and all other International regions.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.